This acquisition opportunity includes an established, licensed addiction treatment enterprise in Los Angeles, consisting of a full-spectrum residential rehab and medically supervised detox program supported by complementary outpatient services under two branded web properties. The operation is mission-driven, clinically grounded, and designed to serve the rapidly expanding demand for high-quality substance use disorder treatment in Southern California.
Service Portfolio
The business provides a continuum of care that includes:
• Medically Supervised Detoxification: 24/7 medical monitoring and safe stabilization for individuals withdrawing from alcohol, opioids, stimulants, benzodiazepines and other substances.
• Residential Inpatient Rehab: Structured, multidisciplinary residential treatment incorporating evidence-based therapies, individualized treatment plans, and clinical oversight.
• Advanced Diagnostic & Personalized Care: Use of pharmacogenetic (PGx) testing and advanced toxicology to tailor medication plans, plus neuromodulation therapies like Electromagnetic Brain Pulse (EMBP) to support psychological stabilization.
• Outpatient Detox & Continuing Care: Flexible outpatient detox tracks and ongoing recovery support designed to extend care beyond initial treatment and improve long-term outcomes.
• Counseling & Dual-Diagnosis Support: Integrated mental health and addiction care, with individual, group, and family counseling services.
The program places strong emphasis on evidence-based practices, personalized treatment planning, and whole-person healing to support clients through the full arc of recovery — from medically unsupported withdrawal to ongoing lifestyle stability.
• Strategic Location: Los Angeles facilities serve one of the highest need markets for addiction services in the U.S., a critical advantage for inbound referrals, insurance partnerships, and service volume.
• Full Continuum of Care: Unlike standalone outpatient or detox providers, this business offers both residential and outpatient care pathways under unified protocols, increasing retention rates and care continuity.
• Science-Driven Treatment Tools: Proprietary use of PGx and neuromodulation puts the program ahead of traditional rehab competitors that rely on generic care models, helping justify premium pricing and differentiate in marketing funnels.
• Scalable Infrastructure: Licensed facilities, established clinical workflows, online admissions capabilities, and branded digital assets position the business for growth through expanded referral networks, contracts with payers, and potential geographic or service line expansion.